These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 17971363

  • 1. Effective treatment of young patients with pediatric-onset, long-standing lupus nephritis with tacrolimus given as a single daily dose: an open-label pilot study.
    Tanaka H, Oki E, Tsugawa K, Nonaka K, Suzuki K, Ito E.
    Lupus; 2007; 16(11):896-900. PubMed ID: 17971363
    [Abstract] [Full Text] [Related]

  • 2. Management of young patients with lupus nephritis using tacrolimus administered as a single daily dose.
    Tanaka H, Oki E, Tsuruga K, Yashiro T, Hanada I, Ito E.
    Clin Nephrol; 2009 Dec; 72(6):430-6. PubMed ID: 19954719
    [Abstract] [Full Text] [Related]

  • 3. Long-term tacrolimus-based immunosuppressive treatment for young patients with lupus nephritis: a prospective study in daily clinical practice.
    Tanaka H, Watanabe S, Aizawa-Yashiro T, Oki E, Kumagai N, Tsuruga K, Ito E.
    Nephron Clin Pract; 2012 Dec; 121(3-4):c165-73. PubMed ID: 23327881
    [Abstract] [Full Text] [Related]

  • 4. Mizoribine treatment of young patients with severe lupus nephritis: a clinicopathologic study by the tohoku pediatric study group.
    Tanaka H, Oki E, Tsuruga K, Sato N, Matsukura H, Matsunaga A, Kondo Y, Suzuki J.
    Nephron Clin Pract; 2008 Dec; 110(2):c73-9. PubMed ID: 18758186
    [Abstract] [Full Text] [Related]

  • 5. Clinical assessment of tacrolimus therapy in lupus nephritis: one-year follow-up study in a single center.
    Asamiya Y, Uchida K, Otsubo S, Takei T, Nitta K.
    Nephron Clin Pract; 2009 Dec; 113(4):c330-6. PubMed ID: 19729969
    [Abstract] [Full Text] [Related]

  • 6. Tacrolimus for the treatment of systemic lupus erythematosus with pure class V nephritis.
    Szeto CC, Kwan BC, Lai FM, Tam LS, Li EK, Chow KM, Gang W, Li PK.
    Rheumatology (Oxford); 2008 Nov; 47(11):1678-81. PubMed ID: 18753192
    [Abstract] [Full Text] [Related]

  • 7. Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients.
    Tanaka H, Tsugawa K, Oki E, Suzuki K, Ito E.
    Clin Rheumatol; 2008 Jan; 27(1):85-9. PubMed ID: 17483980
    [Abstract] [Full Text] [Related]

  • 8. [Effective treatment of a refractory case of systemic lupus erythematosus with low-dose tacrolimus].
    Oki E, Tsugawa K, Suzuki K, Tanaka H.
    Nihon Jinzo Gakkai Shi; 2007 Jan; 49(8):1020-4. PubMed ID: 18186231
    [Abstract] [Full Text] [Related]

  • 9. Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.
    Tanaka H, Tsugawa K, Suzuki K, Nakahata T, Ito E.
    Pediatr Nephrol; 2006 Jul; 21(7):962-6. PubMed ID: 16773408
    [Abstract] [Full Text] [Related]

  • 10. Efficacy of mizoribine-tacrolimus-based induction therapy for pediatric lupus nephritis.
    Tanaka H, Aizawa T, Watanabe S, Oki E, Tsuruga K, Imaizumi T.
    Lupus; 2014 Jul; 23(8):813-8. PubMed ID: 24651669
    [Abstract] [Full Text] [Related]

  • 11. Tacrolimus for induction therapy of diffuse proliferative lupus nephritis: an open-labeled pilot study.
    Mok CC, Tong KH, To CH, Siu YP, Au TC.
    Kidney Int; 2005 Aug; 68(2):813-7. PubMed ID: 16014060
    [Abstract] [Full Text] [Related]

  • 12. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis].
    Cai XY, Yang XY, Chen XH, Liang LQ, Guan MM, Qin SG, Fu JZ.
    Zhonghua Yi Xue Za Zhi; 2004 Sep 02; 84(17):1436-9. PubMed ID: 15500738
    [Abstract] [Full Text] [Related]

  • 13. Long-term outcome of tacrolimus-based immunosuppressive treatment for patients with paediatric-onset lupus nephritis.
    Tanaka H, Aizawa T, Endo M.
    Nephrology (Carlton); 2024 Oct 21. PubMed ID: 39429105
    [Abstract] [Full Text] [Related]

  • 14. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
    Aringer M, Houssiau F, Gordon C, Graninger WB, Voll RE, Rath E, Steiner G, Smolen JS.
    Rheumatology (Oxford); 2009 Nov 21; 48(11):1451-4. PubMed ID: 19748965
    [Abstract] [Full Text] [Related]

  • 15. Tacrolimus is effective for lupus nephritis patients with persistent proteinuria.
    Uchino A, Tsukamoto H, Nakashima H, Yoshizawa S, Furugo I, Mitoma H, Oryoji K, Shimoda T, Niiro H, Tada Y, Yano T, Nonaka T, Oishi R, Akashi K, Horiuchi T.
    Clin Exp Rheumatol; 2010 Nov 21; 28(1):6-12. PubMed ID: 20346231
    [Abstract] [Full Text] [Related]

  • 16. Tacrolimus versus cyclophosphamide as treatment for diffuse proliferative or membranous lupus nephritis: a non-randomized prospective cohort study.
    Wang S, Li X, Qu L, Wang R, Chen Y, Li Q, He X, Zhang X, Wang H, Wu J, Xu Y, Chen J.
    Lupus; 2012 Aug 21; 21(9):1025-35. PubMed ID: 22570338
    [Abstract] [Full Text] [Related]

  • 17. Tacrolimus is an alternative therapeutic option for the treatment of refractory lupus nephritis.
    Lee T, Oh KH, Joo KW, Kim YS, Ahn C, Han JS, Kim S, Chin HJ.
    Lupus; 2010 Jul 21; 19(8):974-80. PubMed ID: 20581020
    [Abstract] [Full Text] [Related]

  • 18. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
    Houssiau FA, Vasconcelos C, D'Cruz D, Sebastiani GD, de Ramon Garrido E, Danieli MG, Abramovicz D, Blockmans D, Mathieu A, Direskeneli H, Galeazzi M, Gül A, Levy Y, Petera P, Popovic R, Petrovic R, Sinico RA, Cattaneo R, Font J, Depresseux G, Cosyns JP, Cervera R.
    Arthritis Rheum; 2004 Dec 21; 50(12):3934-40. PubMed ID: 15593207
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of multitarget therapy with cyclophosphamide and tacrolimus for lupus nephritis: a prospective, single-arm, single-centre, open label pilot study in Japan.
    Sakai R, Kurasawa T, Nishi E, Kondo T, Okada Y, Shibata A, Nishimura K, Chino K, Okuyama A, Takei H, Nagasawa H, Amano K.
    Lupus; 2018 Feb 21; 27(2):273-282. PubMed ID: 28683654
    [Abstract] [Full Text] [Related]

  • 20. Combined low-dose mycophenolate mofetil and tacrolimus for lupus nephritis with suboptimal response to standard therapy: a 12-month prospective study.
    Mok CC, To CH, Yu KL, Ho LY.
    Lupus; 2013 Oct 21; 22(11):1135-41. PubMed ID: 23995863
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.